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The human proteome is rich with protein kinases, and this richness has made the kinase of crucial importance in initiating and
maintaining cell behavior. Elucidating cell signaling networks and manipulating their components to understand and alter
behavior require well designed inhibitors. These inhibitors are needed in culture to cause and study network perturbations,
and the same compounds can be used as drugs to treat disease. Understanding the structural biology of protein kinases in
detail, including their commonalities, differences and modes of substrate interaction, is necessary for designing high quality
inhibitors that will be of true use for cell biology and disease therapy. To this end, we here report on a structural analysis of all
available active-conformation protein kinases, discussing residue conservation, the novel features of such conservation,
unique properties of atypical kinases and variability in the context of substrate binding. We also demonstrate how this
information can be used for structure prediction. Our findings will be of use not only in understanding protein kinase function
and evolution, but they highlight the flaws inherent in kinase drug design as commonly practiced and dictate an appropriate
strategy for the sophisticated design of specific inhibitors for use in the laboratory and disease therapy.
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INTRODUCTION
Protein kinases are the most ubiquitous single family of signaling
molecules in the cell, accounting for approximately 2% of the
proteins encoded by the human genome [1]. The simple
mechanism of attaching an ATP-derived phosphate to a protein
involves kinases in every aspect of cell behavior, from apoptosis to
survival, proliferation to differentiation, maturation etc. Protein
kinases provide a unique opportunity for understanding proteins in
general by presenting us with a seeming paradox: wide scale
similarity of sequence and structure combined with a diversity of
behavioral consequences to their activity. The vast majority of
protein kinases have readily detectable sequence similarity, which
translates into structure. But even those known protein kinases that
show no significant algorithm-detectable similarity at the level of
sequence are believed to have very typical structures, as is
evidenced by specific examples [2,3]. As they all have a shared
function in transferring the terminal phosphate of ATP to another
protein, similarity is understandable. Evidence to date also suggests
a common catalytic mechanism (the possible exception may be the
integrin-linked kinase [4]), whereby ATP and an active site
divalent cation are bound in identical fashions and phospho-
transfer is achieved by a shared set of amino acids. Studies in yeast
[5,6] have shown that kinases can be promiscuous, phosphorylating
hundreds of proteins, but they also have clear specificities. How is
this specificity attained by one family of highly similar proteins? This
paradox suggests the perfection of the kinase as an enzyme: a region
ideally suited for the common function of catalysis, with another
region(s) uniquely modifiable to attain substrate specificity without
altering fold, compromising ligand binding or the subsequent
reaction mechanism. A thorough understanding of this family of
proteins would generate a tremendous knowledge base for
discovering and predicting protein interactions, for designing highly
specific and potent inhibitors, and, as a consequence of these facts,
for understanding the cell and disease.
As protein kinases are the key players in cell signaling,
aberrations in their activity have been directly correlated with
numerous disease states (for example, breast cancer [7] and
chronic myeloid leukemia [8]) and made them potential targets for
drug design in many other diseases (for example, Crohn’s [9] and
cerebral vasospasm [10]). This has made the kinase the drug target
of choice [11]. However, there is an inherent flaw in traditional
kinase inhibitor design. Almost all inhibitors target the ATP
binding pocket based on a simple principle: if ATP cannot be
bound, phosphorylation cannot occur. Building a molecule that
can occupy this pocket is relatively simple, but since the ATP
binding pocket and the regions in its immediate vicinity are the
areas of greatest conservation, building a specific inhibitor is
impossible. The inherent multi-target nature of inhibitors has been
demonstrated by Fabian et al. [12], where the twenty compounds
tested had multi-target coverage with only 23% of the kinome
screened. Other ATP binding proteins could very likely display
affinities for these compounds as well, making these inhibitors not
just multi-kinase but multi-enzyme. In the laboratory, how can the
effect of treating cells with such inhibitors be dissected? And when
used for disease, what non-intended effects may arise in the
targeted cell type or others over the long term? In the hopes of
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PLoS ONE | www.plosone.org 1 October 2007 | Issue 10 | e982producing specific inhibitors, what is needed is a new approach to
kinase drug design, one which logically targets the region of
greatest dissimilarity.
True dissimilarity can be known if similarity or conservation is
understood in detail. For this, structure-based comparative
approaches are needed to fully extract the information hidden in
the three-dimensional protein-structure space. Traditional struc-
ture-driven alignment studies concentrate on maximizing fold
overlap, and for the highly-similar protein kinase family which has
a largely conserved fold, this can be a useful approach. But it is not
necessarily the correct one, particularly where inhibitor design is
concerned. Due to the information available in a three-di-
mensional space, structures can be aligned in other ways, for
example by using geometry independent of connectivity. Fold can
be ignored and focus directed upon residues free from their
covalent associations. The positioning of side-chains and those
functional groups involved in enzymatic catalysis and protein
interactions can be directly overlain for studying similarity and
variability. This type of alignment, and not that of fold, is of
greater relevance for understanding protein interactions and
therefore in designing small molecules or peptides to act as
inhibitors.
Understanding the similar/conserved and dissimilar/non-con-
served aspects of protein kinases allows for effective drug design. In
addition, conservational studies will aid especially in structure
prediction. There are at least 518 known human protein kinases
[1] and deriving crystal structures for them all would involve
a great deal of time and effort. As all known protein kinases have
similar structures, homology-driven approaches to structure pre-
diction that incorporate knowledge of conservation should prove
fertile. Having a reliable predicted structural kinome would be of
great practical use.
In this paper we report on a structural analysis of and
a modeling approach to active-conformation protein kinases. We
describe the variability found between these kinases in terms of
fold and amino-acid side-chain positioning. These results were
produced using a novel structural alignment algorithm that will
also be described. This algorithm superimposes structures in-
dependent of fold to maximize side-chain similarity. The result is
not only an alignment but a consensus structure that depicts
residue conservation as a distribution of amino acids and amino-
acid categories. This consensus can be used to guide structure
prediction, and we report here on its successful use with Rosetta
[13] in predicting the structure of 3-phosphoinositide dependent
protein kinase-1 (PDK1) and the atypical protein kinase Rio2.
RESULTS
Alignment
To examine conservation and variability between protein kinases
we focused on a group of active-conformation structures.
Obviously, it is important to examine like conformations so that
any observed variability is in fact real. We defined an active kinase
structure as one with ATP or a non-hydrolysable ATP analog, at
least one divalent cation (always Mg
2+ or Mn
2+), and any
necessary phosphorylations. Kinases can be constitutively active
or be regulated positively or negatively by phosphorylation, which
is ultimately kinase specific. Information regarding the kinase
structures used in our analysis can be found in Table 1, and an
example of an active-conformation protein kinase is shown in
Figure 1.
Fifteen kinase structures were aligned using the sequence-order
independent algorithm outlined in the Methods section to yield
a consensus set of forty-four fully and partially conserved residues.
The complete set is listed in Table 2. The structural alignment
produced is shown in Figure 2. From such an image it can be
seen that the overall kinase shape is a highly conserved feature.
The active site occurs between two lobes: the small lobe above
ATP and the large lobe below. Of particular importance for later
discussion is the conservation of the substrate-binding groove,
located between the catalytic loop, the P+1 loop, helix D, helix F,
helix G and helix H. Conserved residues are shown in Figure 3,
Table 1. Active-conformation kinase structures.
*
..................................................................................................................................................
Kinase Full name Species PDB code Pfam domain (residues)
ACK1 activated CDC42 kinase 1 H. sapiens 1U54 [46] Protein tyrosine kinase (126-385)
Akt2 RAC-b serine/threonine-protein kinase H. sapiens 1O6K [25] Protein kinase (152-409)
CDK2 cell division protein kinase 2 H. sapiens 1JST [47] Protein kinase (4-286)
CK1 casein kinase I S. pombe 1CSN [48] Protein kinase (12-237)
CK2 casein kinase II subunit a Z. mays 1LP4 [49] Protein kinase (34-319)
DAPK death-associated protein kinase H. sapiens 1IG1 [50] Protein kinase (13-275)
IRK insulin receptor tyrosine kinase H. sapiens 1IR3 [51] Protein tyrosine kinase (1023-1290)
MAPK p38c mitogen-activated protein kinase p38c H. sapiens 1CM8 [52] Protein kinase (27-311)
PhK phosphorylase kinase O. cuniculus 1PHK [53] Protein kinase (19-287)
Pim-1 proto-oncogene serine/threonine-protein kinase Pim-1 H. sapiens 1XR1 [54] Protein kinase (129-381)
PKA protein kinase A M. musculus 1ATP [23] Protein kinase (43-297)
PknB probable serine/threonine-protein kinase PknB M. tuberculosis 1MRU [55] Protein kinase (11-273)
Rio2 Rio2 serine kinase A. fulgidus 1ZAO [56] Rio1 family (105-275)
Sky1P SR protein kinase S. cerevisiae 1Q97 [57] Protein kinase (158-706)
{
TAO2 thousand and one amino-acid protein 2 R. norvegicus 1U5R [58] Protein kinase (28-281)
ChaK
{ transient receptor potential channel kinase M. musculus 1IA9 [2] Alpha kinase (1596-1814)
*The average pair-wise sequence identity between this set as computed by ClustalW using its default parameters is 17%.
{Residues 304-541 constitute a large spacer within the kinase domain [59].






















































































PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e982in what we term a consensus structure. This is a distribution of
amino acids and amino-acid categories conserved between the
protein kinases we have examined. The consensus structure has
three principle parts: 1) a region of hydrophobic residues clustered
around the adenosine of ATP; 2) an area around the c-phosphate
of ATP – the active site – enclosed primarily by charged residues;
and 3) a region in the large lobe, situated below ATP, of both
hydrophobic and polar residues. The hydrophobic region around
the adenosine creates a binding pocket for ATP. The charged
residues in the active site bind and position the c-phosphate, as
well as the divalent cation, and participate in the catalytic
mechanism. The conserved residues located in the large lobe serve
to stabilize that region, and may play a role in mediating substrate
interactions. Only five specific amino acids are fully conserved in
all the kinases. These residues play critical parts in positioning
ATP, stabilizing the active-conformation and in the catalytic
mechanism. These are lysine 8, which interacts with the a- and b-
phosphates of ATP, thereby stabilizing it. Glutamic acid 9, which
forms a salt bridge with lysine 8 further stabilizing ATP. Aspartic
acid 24 is the catalytic base that initiates phosphotransfer by
deprotonating the acceptor serine, threonine or tyrosine. Aspar-
agine 27 interacts with a secondary divalent cation, thereby
positioning the c-phosphate of ATP. And the final fully conserved
residue is aspartic acid 34, which chelates the primary divalent
cation, indirectly positioning ATP at the same time. Although
these are the only residues fully conserved in terms of function,
location and amino-acid type, there is one other residue with
functional conservation but not locational or type, and in other
kinases there is variability in the origin of lysine 8 and the type of
amino acid fulfilling its role.
Rio2, ChaK and conserved residue variability
Rio2 is the only atypical protein kinase amongst those included in
our multiple alignment. No significant sequence similarity can be
detected between Rio2 and conventional protein kinases. As such,
it is classified with a distinct domain name (see Table 1). The
structure of the Rio family, as initially determined by [14], shares
significant similarity with serine/threonine and tyrosine kinases in
the small lobe and in the regions of the large lobe directly adjacent
to the active site (Figure 4A). Dissimilarity in structure occurs
predominantly in the large lobe, in regions involved in substrate
specificity, suggesting Rio2 has evolved a novel mechanism of
substrate recognition [14]. Our structural alignment algorithm
concurs with these findings, showing high similarity in and around
the active site (consensus residues 1–36) but not in the large lobe
(consensus residues 37–44).
Slightly different results are produced for another atypical
protein kinase: channel kinase (ChaK). The structure of this kinase
was not included in our initial data set because it lacked a divalent
cation in the active site. To examine structural similarity between
ChaK and conventional protein kinases, we did align the partially
active structure of ChaK (Figure 4B) with the consensus structure
generated from fully active-conformation kinases (see Table 2).
Most similarity is found in the region directly around the c-
Figure 2. Multiple kinase alignment. The fifteen active-conformation
kinase structures listed in Table 1 were aligned using our modified
Procrustes approach. Shown in green sticks is the ATP or ATP analog
molecule of each structure. Each kinase is colored uniquely.
doi:10.1371/journal.pone.0000982.g002
Figure 1. The structure of protein kinase A (PKA). PKA is shown in its
active conformation with ATP in green sticks and Mn
2+ as black spheres.
b-strands, helices and loops are labeled as in Knighton et al. [45]. The
active site is situated between the small and large lobes, located above




PLoS ONE | www.plosone.org 3 October 2007 | Issue 10 | e982Table 2. Conserved residues found in the active-conformation kinases listed in Table 1.
..................................................................................................................................................
Type ACK1 Akt2 CDK2 CK1 CK2 DAPK IRK p38c PhK Pim-1 PKA PknB Rio2 Sky1P TAO2 Chak
*
1 h L132 L158 I10 I18 V45 L19 L1002 V33 L25 L44 L49 L17 M98 L164 I34 x
2 G 133 159 11 19 46 20 1003 x 26 45 50 18 x 165 35 x
3 G x 161 13 21 48 22 1005 x 28 x 52 20 x 167 37 1619
4 V 140 166 18 I26l 53 27 1010 41 33 52 57 25 106 172 42 A1624l
5 h V155 Y178 V30 V38 C65 Y39 V1027 V53 Y45 V64 Y69 V37 C117 V184 V54 Y1643
6 A 156 179 31 39 I66l 40 1028 54 46 65 70 38 V118l 185 55 I1644l
7 h V157 M180 L32 I40 I67 A41 V1029 I55 V47 I66 M71 V39 V119 M186 I56 I1645
8 K 158 181 33 41 68 42 1030 56 48 67 72 40 120 187 57
1646/
R1622b
9 E 1 7 7 2 0 0 5 1 5 58 1 6 41 0 4 7 7 47 38 99 15 91 5 4 2 0 2 7 61 6 7 2
10 L M181h 204 55 Y59h 85 68 M1051h 78 77 93 95 A63l 158 206 80 x
11 L 192 215 66 V71l 97 79 1062 89 89 106 106 V74l V169l 228 Y91h x
12 h M203 F227 L78 L83 L111 L91 V1074 L107 L101 L118 M118 I90 V177 M244 L103 A1716
13 V 204 228 79 84 I112l I92l 1075 108 102 I119l 119 91 L178l 245 104 1717
14 E 206 230 81 x 114 94 1077 x x 121 121 93 180 x 106 x
15 h A208 A232 L83 L88 V116 V96 M1079 M112 M106 P123 V123 V95 I182 L249 C108 M1721
16 L x 237 87 92 x 101 1084 116 111 129 M128h 100 187 253 A112l x
17 h V236 I259 L111 M115 L140 I123 I1116 M137 L133 V151 I150 A122 I202 L277 A135 M1746
18 h M240 L263 L115 V119 L144 V127 M1120 L141 I137 V155 F154 L126 V206 L281 L139 F1749
19 H x 267 119 123 148 131 x 145 141 159 158 130 x 285 143 T1753p
20 h F248 V271 V123 L127 I152 I135 F1128 I149 I145 V163 L162 I134 I214 I290 M147 A1678
21 h I249 V272 L124 V128 M153 A136 V1129 I150 V146 L164 I163 I135 V215 I291 I148 x
22 H 250 Y273r 125 Y129r 154 137 1130 151 147 165 Y164r 136 216 292 149 x
23 R 251 274 126 130 155 x 1131 152 148 166 165 137 x x 150 x
24 D 252 275 127 131 156 139 1132 153 149 167 166 138 218 294 151 1765
25 l L253 I276 L128 I132 V157 L140 L1133 L154 L150 I168 L167 V139 L219 I295 V152 L1766
26 K R256b 277 129 133 158 141 R1136b 155 151 169 168 140 S220p 296 153 1727
27 N 257 280 132 136 161 144 1137 158 154 172 171 143 223 299 156 Q1767p
28 h L258 L281 L133 F137 V162 I145 C1138 L159 I155 I173 L172 I144 V224 V300 I157 x
29 h L259 M282 L134 L138 M163 M146 M1139 A160 L156 L174 L173 M145 L225 L301 L158 x
30 h L260 L283 I135 I139 I164 L147 V1140 V161 L157 I175 I174 I146 V226 M302 L159 x
31 l V266 I289 I141 I150 L171 I157 V1146 L167 I163 L182 I180 V152 I231 I546 V165 x
32 K 267 290 142 Y151p R172b 158 1147 168 164 183 Q181p 153 x 547 166 N1772p
33 l I268 I291 L143 V152 L173 I159 I1148 I169 L165 L184 V182 V154 I233 I548 L167 L1773
34 D 270 293 145 154 175 161 1150 171 167 186 184 156 235 550 169 x
35 F 271 294 146 155 W176r 162 1151 172 168 187 185 157 236 L551h 170 P1776h
36 G 272 295 147 156 177 163 1152 173 169 188 186 158 P237s 552 171 x
37 P 299 319 171 x 200 186 1178 194 192 210 207 185 x 573 191 A1806s
38 E 300 320 172 N188p 201 187 1179 195 193 211 208 186 x 574 192 x
39 D 312 332 185 200 214 199 1191 208 211 x 220 198 x 586 207 x
40 W 314 334 187 x 216 201 1193 210 213 226 222 Y200r x 588 209 x
41 G 317 337 190 205 219 204 1196 213 216 229 225 203 I259l A591v 212 x
42 h C367 L384 M266 Y256 L304 L255 C1245 M291 F267 C270 L272 A254 I259 M686 C261 x
43 L W368h 385 267 M257h 305 256 W1246h 292 268 271 273 255 x 687 262 x
44 R 375 392 274 x 312 263 1253 299 275 278 280 262 x 694 269 x
*ChaK was aligned directly onto the consensus generated from the other fifteen samples. See Results section.
The amino acid or amino-acid category of the conserved residue is listed under ‘‘type’’. For each structure the residue identifier corresponding to the conserved point is
indicated (listed as x if the point is absent). For category types the amino acid present in each structure is indicated before the identifier. If a sample is missing
a conserved amino acid but has a similar residue in the same location then the shared category is listed after the identifier. a, acidic; l, aliphatic; r, aromatic; b, basic; c,






































































































































































































PLoS ONE | www.plosone.org 4 October 2007 | Issue 10 | e982phosphate of ATP, although there is some elsewhere. The large
lobe, like Rio2, is quite distinct. One of the few differences between
this kinase and the others is that the fully conserved asparagine 27 is
replaced bythe verysimilar carboxamide containing glutamine. The
fully conserved aspartic acid 34 is present but does not align, likely
due to the absence of a divalent cation.
We highlight these two kinases for the additional reason that
they demonstrate structural variation within the bounds of certain
functional constraints. An interesting case of this is lysine/arginine
26. In almost all serine/threonine kinases there is a lysine residue
located two positions downstream of the catalytic aspartic acid
(consensus residue 24). This lysine aids in orientating the c-
phosphate of ATP and it is thought may also act to neutralize the
negative charge on this phosphate during catalysis. The position
and orientation of these two residues with respect to ATP is shown
in protein kinase A (PKA) in Figure 5A. Tyrosine kinases, like
activated CDC42 kinase (ACK1), do not have this lysine but
instead have an arginine four positions downstream from the
catalytic residue (Figure 5B). This residue is orientated
perpendicular to the lysine but occupies the same location, and
since both are positively charged basic residues, both can fulfill the
same function. ChaK, a serine/threonine kinase like PKA, utilizes
a lysine for this function, which again occupies the same geometric
position (Figure 5C). However, this residue is not located two or
four positions downstream, but thirty-eight positions upstream on
a b-strand running adjacent to the catalytic loop. This is a good
demonstration of the value behind a sequence-order independent
alignment algorithm that ignores fold and residue connectivity.
This lysine is located on part of a novel fold not found in any of the
other kinases examined. Rio2 presents a fourth variation. Our
alignment did not reveal Rio2 as having a basic residue at
consensus point 26, as it did for all of the other kinases. Further
examination led us to the conclusion that the function of this
residue is conserved in Rio2 but the location of the residue
accomplishing it is not (see also [14]). This is known as functional
residue hopping [15,16]. The function of consensus residue 26 is
performed by a histidine located in the small lobe (Figure 5D).
This histidine is largely unique to the Archaeoglobus fulgidus Rio2
ortholog, from which the structure was derived – in most other
species it is substituted by an arginine. As A. fulgidus is
a hyperthermophile, the preference for histidine may be due to
the extreme temperature environments in which it is found.
The only other variability we have found in conserved residues
is for the so-called catalytic lysine (lysine 8). The function of this
residue is somewhat debated [17,18,19], but at the very least it
appears to position the phosphates of ATP and is absolutely crucial
for catalysis. This residue is normally found on b-strand 3 and
interacts with the a- and b-phosphates of ATP (Figure 6A). In
ChaK there is a homologous lysine present but it interacts with the
a-phosphate and the adenine ring of ATP (Figure 6B). Depend-
ing upon the alignment parameters used, this lysine can align
structurally with that found in other kinases, although for the
parameters we have chosen it does not. Instead there is an arginine
residue that aligns and this very similar residue interacts with both
the a- and b-phosphates of ATP (Figure 6B), just as the catalytic
lysine normally does. Although ChaK lacks a divalent cation, this
is unlikely to affect the positions of these residues. The arginine in
question, R1622, is fully conserved in the alpha kinase family [20].
Figure 3. A kinase consensus structure. Each sphere represents a conserved residue. Red indicates full conservation of a particular amino acid in all
fifteen kinase structures; orange, conservation in thirteen or fourteen structures; and yellow, conservation in eleven or twelve structures. Blue spheres
indicate full conservation of an amino-acid category. The ATP molecule of protein kinase A is shown in green sticks. (A) The consensus structure
consisting of the forty-four points listed in Table 2. (B) The consensus structure overlaid on the multiple alignment.
doi:10.1371/journal.pone.0000982.g003
Modeling Protein Kinases
PLoS ONE | www.plosone.org 5 October 2007 | Issue 10 | e982It is not known which residue in ChaK is functionally homologous
to the catalytic lysine in typical protein kinases. Likely both share
the function, and this represents a distinct feature of the alpha-
kinase family. One other kinase is known to have a novelty in this
area. This is the protein kinase with no lysine (WNK) kinase,
named for the apparent absence of the catalytic lysine on b-strand
3. It was predicted by [21] that a lysine on b-strand 2 could be
structurally equivalent (Figure 6C), and the absolute requirement
for a lysine at this position was confirmed by this group. A
subsequent crystal structure appears to confirm these predictions
[22]. It is interesting that this lysine originates from the same
position as the arginine in ChaK, showing that variation in
conserved residues is possible and highlighting how proteins can
incorporate novel features within certain functional constraints.
Substrate specific variation
The conservation we are detecting is found first and foremost in
and around the active site, but is present elsewhere in the protein
kinase domain. The single exception is in the cleft formed by the
catalytic loop, the P+1 loop, helix D and the residues from the end
of helix F through to the beginning of helix H. This is known as
the substrate-binding cleft, and residues in this region have been
shown crucial to substrate binding and regulatory protein-protein
interactions [23,24,25,26,27,28,29]. The absence of conservation
in this cleft is entirely expected. Protein kinases are substrate
specific and that specificity is at least in part conferred through
residue variability within this groove.
The crystal structures of PKA and Akt we have used in our
analysis contain substrate peptides bound in this region. In Figure 7
we show PKA and Akt with bound substrate peptides and display
variability in the context of proximity to the substrate and distance
from conserved residues. In both PKA and Akt, there are a number
of atoms in the substrate-binding cleft adjacent to or near the
substrate peptide that are distant from conserved residues. We
highlightthisforthepurposeofdiscussinginhibitordesign.Successful
inhibitor design requires a region where small molecules or peptides
can be bound with high specificity. The absence of specificity comes
from drug targets hitting regions of residue conservation. The
substrate-binding cleft obviously has a binding capacity and, as
shown, this region is highly variable. Designing inhibitors that target
the atoms in this region, mimicking those residues present in
substrates or regulatory proteins, would be a fruitful approach.
Structure prediction
The conservation we are finding can be used for purposes other
than understanding protein function, evolution and guiding drug
design. It can also be used to predict the structure of protein
kinases (and to other proteins if applied). The consensus structure
shown in Figure 3 represents the typical position of specific and
conserved amino acids or amino-acid categories. If this is
a distribution that active protein kinases tend to adopt, then
predicted structures of active-conformation protein kinases should
be made to meet these criteria. At the most basic level, models can
be generated through any method and then screened against
a consensus structure to discriminate between good and bad
models, or, alternatively, residues known to be equivalent from
a sequence alignment can be forced to meet the constraints seen in
the consensus structure and the rest of the protein can be modeled
within this framework. We have explored these possibilities with
the structure prediction method Rosetta [30] and attempted to
model two kinases, the typical 3-phosphoinositide dependent
protein kinase-1 and the atypical Rio2 kinase.
Figure 4. The atypical kinases (A) Rio2 and (B) transient receptor potential channel kinase (ChaK).
doi:10.1371/journal.pone.0000982.g004
Modeling Protein Kinases
PLoS ONE | www.plosone.org 6 October 2007 | Issue 10 | e982We used fourteen active-conformation kinases (omitting Rio2)
and generated a 52 residue consensus structure (consensus residues
are listed in Supplementary Table S1). A sequence alignment
of these fourteen kinases and PDK1 was then generated using
ClustalW [31]. Residues from PDK1 apparently equivalent with
those of the consensus were selected based on this sequence
alignment (see Supplementary Table S1). These residues were
then constrained geometrically in accordance with the consensus
while PDK1 was modeled with Rosetta as described in the
Methods section. When compared against the partially active-
conformation structure of PDK1 (PDB code: 1H1W, [32]), the top
ranked prediction had 198 of 285 side chains positioned within
2A ˚ of their actual location, a Ca RMSD of 1.3 A ˚ and an all-atom
RMSD of 1.6 A ˚ (Figure 8A). The floor of the active site, where
most conservation occurs, is highly accurate, with 24 of 25 side
chains positioned with 2 A ˚,C a RMSD of 0.5 A ˚ and an all-atom
RMSD of 0.7 A ˚ (Figure 8B). In non-conserved regions, such as
the substrate-binding groove, good modeling is dependent upon
the ability of the prediction method applied. A well-proven
method like Rosetta is, therefore, a good complement. 24 of 38
residues in the substrate-binding groove are within 2 A ˚ of their
actual position, a Ca RMSD of 0.9 A ˚ and an all-atom RMSD of
1.4 A ˚ (Figure 8C). Accuracy in this region may be due in part to
the constraints applied elsewhere, which would reduce the
potential conformational space to search.
Rio2 kinase was modeled initially without constraints as these
cannot be derived from a sequence alignment. 80,000 models were
generated and the lowest 5% (in full atom energy) were screened
against the consensus structure. The top ten were then scrutinized
for potential constraints. All ten of the top models unambiguously
agreed on the likely equivalent residues for the fully conserved
lysine 7 (K120 in Rio2), aspartic acid 24 (D218), asparagine 27
(N223) and aspartic acid 34 (D235). In none of the models could
a residue equivalent to the fully conserved glutamic acid 8 be
Figure 5. Residue variability in positioning the c-phosphate of ATP. In each kinase the catalytic aspartic acid is shown in red and the positively-
charged residue that interacts with the c-phosphate of ATP is shown in yellow with nitrogen atoms colored blue. ATP is shown in green sticks. (A)
Protein kinase A, (B) activated CDC42 kinase 1, (C) channel kinase, and (D) Rio2 kinase.
doi:10.1371/journal.pone.0000982.g005
Modeling Protein Kinases
PLoS ONE | www.plosone.org 7 October 2007 | Issue 10 | e982found (it should be E154). We then proceeded with a second
modeling phase using constraints from the consensus for K120,
D218, N223 and D235, and allowing two candidates for the
conserved glutamic acid: E134 or E154. Although models
generated with E134 as the conserved glutamic acid scored
equally well when compared against the consensus structure, they
would likely be deemed implausible by visual inspection as helix C
was distorted upwards away from the active site instead of lining
the back of the ATP binding pocket as it does in other kinases. The
best model for E154 as determined against the consensus structure
is shown in Figure 9A alongside the actual active-conformation
structure (PDB code: 1ZAO). Fifty four of 180 side-chains are
positioned within 2 A ˚ of their true location. Ca and all-atom
RMSD are 6.1 A ˚ and 7.1 A ˚ respectively. However, these values
do not accurately reflect the quality of the model. The N-terminus
of protein kinases is a non-conserved region and the C-terminal
lobe of Rio2 differs greatly from that of other kinases. It should not
be expected that a structural-based consensus approach would be
able to distinguish a correct model from an incorrect model in
these regions. Looking solely at the conserved kinase regions,
comprising residues 93–242 of Rio2, the Ca and all-atom RMSD
drop to 3.0 A ˚ and 3.7 A ˚ respectively. And all of the correctly
positioned residues are found in this region. The floor of the
active site has 16 of 24 side chains positioned with 2 A ˚,C a RMSD
of 1.0 A ˚ and an all-atom RMSD of 1.7 A ˚ (Figure 9B). A final
note: although residues located in the non-conserved large lobe
helices are not correctly positioned, this region is topologically
correct.
Figure 6. Variations in the catalytic lysine. (A) In almost all protein kinases (such as protein kinase A shown) a lysine residue originating from b-
strand 3 interacts with the a- and b-phosphates of ATP. This lysine is required for catalytic activity and has been termed the catalytic lysine. (B) In
channel kinase (ChaK), the homologous lysine interacts with the a-phosphate and the adenine ring of ATP. An unique arginine residue located on b-
strand 2 instead interacts with the a- and b-phosphates. (C) In protein kinase with no lysine 1 (WNK1, PDB code: 1T4H [22]), the catalytic lysine is
present but originates from b-strand 2, much like the arginine from ChaK. ATP is shown in green sticks. Potential hydrogen bonds between the
positively charged residues and ATP are shown as dashed lines, and nitrogen atoms are colored blue. The WNK structure has no ATP or ATP analog.
doi:10.1371/journal.pone.0000982.g006
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The kinase domain can be conceptualized as two functional
modules. A highly conserved ATP-binding and catalytic module,
located between the small and large lobes, found in all typical and
atypical protein kinase structures. Little variation is found here,
with only a few kinases, such as Rio2, ChaK and WNK,
containing structural (but not functional) novelties. The second
module is involved in substrate binding and evidence suggests is
localized primarily to the large lobe, in the region named the
substrate/peptide binding groove (named from kinase-peptide co-
crystal structures). Very little is known about this region of kinases
as detailed knowledge would require many kinase structures co-
crystallized with full-length substrates, and as yet no single such
structure exists. Conservation of the groove fold suggests
a common substrate-binding mechanism, while the absence of
residue conservation in this region across the kinase family suggests
the means by which substrate specificity is determined. The part of
this groove located near the active site (between the catalytic and
P+1 loops) does contain conserved residues and is entirely
consistent with the broad peptide-substrate specificity of kinases.
But peptides are not the same as full-length proteins, and studies
on the mitogen-activated protein kinase p38 have shown that
proteins can be phosphorylated at a hundred to thousand fold
Figure 7. Substrate-specific variability. Cross-eyed stereo views of (A) protein kinase A and (B) Akt2. Bound substrate peptides are shown in red
sticks. Atoms belonging to non-conserved residues within 10 A ˚ of the substrate peptide are shown as colored spheres. Red: atoms within 2 A ˚ of
a conserved residue; orange: atoms between 2 and 4 A ˚ of a conserved residue; yellow: atoms between 4 and 6 A ˚ of a conserved residue; green:




PLoS ONE | www.plosone.org 9 October 2007 | Issue 10 | e982greater rate than peptides [33]. More than just the residues
immediately attached to and surrounding the target serine,
threonine or tyrosine are involved in the kinase-substrate in-
teraction, and the general mechanism of interaction needs to be
determined.
Although the substrate/peptide binding groove may be the key
feature for understanding substrate specificity in most kinases, it is
and need not be in all. The substrate-binding module can vary in
three ways: typical kinases that preserve fold and merely vary the
residues in the substrate-binding groove, typical kinases than rely
on other regions/regulatory proteins in addition to the substrate-
binding groove, and atypical kinases that vary the binding
mechanism all together. It should be added that even in very
typical kinases substrate interactions are not localized purely to the
substrate-binding groove (see [34]). Much work needs to be done
on this area of protein kinases, and current knowledge of substrate-
binding mechanisms is rudimentary.
A thorough understanding of substrate interactions will help in
discovering new proteins targeted by kinases. Insights into binding
can guide computational docking approaches that test the fit of
different structures onto kinases as a new means of substrate
finding. More experimentally determined structures or advances in
structure prediction would be a necessary requirement for this to
have broad applicability. This may be a ways off yet, but a closer
goal may be in applying structural binding information to the
design of specific kinase inhibitors. Currently, inhibitors are
primarily designed to target the ATP binding pocket, the region of
greatest conservation amongst kinases. The ATP binding pocket
does contain unique features between certain subsets of the
kinome (the gatekeeper residue is an example [35,36]), and these
novelties can be exploited by drugs. However, this type of design
approach will always be plagued by problems of specificity on the
simple foundation that this region has evolved to bind a single
thing: ATP. On the other hand, the substrate-binding groove has
evolved to bind kinase-specific substrates and our analysis
demonstrates that this is accompanied by large variability in the
substrate-binding groove. Mimicking these substrates with pep-
tides or small molecules that compete with substrates has proven
effective in several cases (reviewed in [37]), and a peptide inhibitor
that mimics a substrate interaction domain has been shown useful
in vivo at reducing tumor mass [38].
Of great benefit in this regard would be data on kinase
substrates. If wide-ranging data on kinase substrate pools were
known, inhibitors could be designed to mimic exclusive targets. Or
if there was a desire to inhibit multiple kinases at one time, a small
molecule that mimics a common substrate could be made.
Ultimately the viability of such a strategy would again require
a greater output of crystal and NMR structures, advances in
structure prediction and protein docking, but these are popular
areas of research and should not prove a hindrance. A dendro-
gram classification of kinases based upon substrates would be of
tremendous use for inhibitor design, cell biology and evolutionary
studies. Such an aim would require systematic methods of
substrate finding, which are beginning to become available [39,6].
Protein structures are the key to what we have presented and
are discussing. Unless there are significant advances in the rate and
ease with which proteins can be cloned, expressed, purified and
structures subsequently determined, reliable computational ap-
proaches at structure determination will be needed. We have
found that structural conservation gives insight not only into
protein function but also can be used with success for structure
prediction. We have shown how knowledge of residue conserva-
Figure 8. Modeling a typical kinase. PDK1 was modeled using the consensus guided approach outlined in the Results and Methods sections. (A) The
best model is in blue and the actual structure in red (PDB code: 1H1W). Structures are shown aligned based on Ca RMSD. (B) Residues 201–225,
comprising the floor of the active site, are highlighted as aligned on side chains. (C) Residues from the non-conserved regions of the substrate
binding groove (residues 166–175 and 278–305) are shown as aligned on side chains. ATP from the true structure of PDK1 is shown in green sticks.
doi:10.1371/journal.pone.0000982.g008
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models. The atypical Rio2 kinase, which possesses no significant
sequence similarity to other protein kinases, would be a difficult
target for standard approaches at homology modeling. As few as
five geometric residue constraints derived from a consensus
structure and further screening can select a highly accurate
model. For a typical kinase, such as PDK1, where many
constraints can be used (50 in our case), it was a simple matter
to generate a highly accurate model. Residue conservation and
other types of structural similarity quantified over protein families
can provide the basis for model selection and act as guides that
reduce the target search space for the computationally demanding
task of structure prediction.
Understanding the individual role of every protein kinase in the
genome is a daunting task, but necessary because of the important
signaling role played by this family of enzymes and the potential
for disregulation and subsequent disease. Ultimately, cellular
studies that dissect the role of kinases in vivo and the treatment of
disease will require a library of specific and multi-target inhibitors.
Such an aim will require a strong union between computational,
molecular and structural approaches, but this goal may be close at
hand. Although empirically determined structures of all kinases are
a long way off, quality models can be built. Kinome wide data on
substrate pools will require a great deal of work, but the techniques
are now becoming available. The mechanism(s) of substrate
binding will need to be elucidated in detail. This may be the
greatest challenge, and towards which maximum focus should be
directed, as not a single kinase-substrate structure exists. But, if
such can be achieved in a representative sample of cases, kinase-
substrate specific docking algorithms may be able to do the rest.
The attainment of these aims would allow for the quick and
reliable design of specific inhibitors, thereby allowing the precise
function(s) of kinases to be determined and creating the means by




a multiple structure alignment algorithm we have developed. The
motivation was to have a method for superimposing protein
structures independent of residue connectivity, thereby facilitating
comparisons between proteins that have distinct folds and maximize
side-chain as opposed to main-chain overlap. The field of shape
analysis, specifically the Procrustes methods, provided the founda-
tion for accomplishing this task. What follows is an overview of
Procrustes and a description of its modification and application to
protein structure comparison as we have implemented it.
Procrustes
Procrustes is a method for comparing matrices and thereby any
group of objects that can be represented in such a way [40,41]. It is
part of the broader field of shape analysis which has its motivation
in describing and understanding variation between objects through
multivariate analysis. Procrustes is often applied in biological and
anthropological studies of morphology, for example in studying
the relationship between turtle skull shape and life style across
species [42]. It has been used in agriculture, genetics, geography,
geology and psychology to name a few fields. Although
multivariate analysis is not of interest, the Procrustes method is
valuable for its ability to efficiently superimpose objects. Procrustes
superimposition initiates from a set of points, each of which has
a representative in every object under consideration. These points,
known as landmarks, must have some level of correspondence and
Figure 9. Modeling an atypical kinase, Rio2. (A) The best model is in
blue and the actual structure in red (PDB code: 1ZAO). Structures are
shown aligned based on Ca RMSD. Residues 128–142 from the model
are hidden because they are disordered in the actual structure. (B)
Residues 214–237 are highlighted as aligned on side-chains. ATP is
shown in green sticks.
doi:10.1371/journal.pone.0000982.g009
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location and orientation, Procrustes aims to produce an optimal
superimposition as defined by some criteria that acts to minimize
distance between corresponding points. The term partial Procrus-
tes specifically refers to the subset of methods that maintain scale,
i.e. those approaches that only perform rigid body transformations
[43].
Application and algorithm
An application for Procrustes in protein structure alignment is
evident, where landmarks could be viewed as equivalent residues
in a space of three dimensions. The term equivalent accounts for
functional equivalence and/or homology, although emphasis
should be placed on the former. Specifically it is the partial
Procrustes method that is applicable since initial aspects of scale
should be maintained in the resulting alignment.
Standard implementations of Procrustes require a set of user-
specified landmarks with representatives in every input object.
These two conditions are inadequate for multiple structure
alignments. The primary motivation behind a structural alignment
should be to find conserved residues, and a good algorithm must
give leeway for less than total conservation. The algorithm we
have developed allows for both. It proceeds in two phases. The
first is a series of pair-wise comparisons to find residues conserved
across all samples. Residue conservation means in terms of both
location and amino-acid type (identity/similarity). The second
phase begins with an initial multiple alignment using the
landmarks found in the first phase. From the multiple alignment
the set of landmarks is then extended to include any additional
fully conserved residues not found in the first phase, and residues
with less than total conservation. The multiple alignment and
extension steps are repeated until a final non-extendable set is
obtained or upon completion of a predefined number of iterations.
In this approach, each of n structures is represented by a li63
coordinate matrix, where li equals the number of residues in
structure i. The mean of the non-hydrogen side chain atoms is
used as the coordinate for each residue, with the exception of glycine
residues for which the alpha carbon (Ca) is used. Most structure
alignment algorithms use the Ca for all residues. This is inadequate.
Residue function should be viewed largely in terms of side-chain
characteristics: what atoms make up the side chain and where they
are positioned. It is the side chain that is principally used to interact
with ligands, substrates and other residues [44], making knowledge
of its position the crucial feature. Superimposed Ca’s of similar
residues may have side chains positioned in different locations and
are therefore unlikely to have the same function. For these reasons
focus is placed on side-chain positioning.
One object (structure) can be superimposed onto a second in
three dimensions if at least three equivalent residues are known. It
is possible these residues may or could be known beforehand,
although this is not ideal. An alternative involves a search and
score approach: choose three residues from each sample that have
corresponding amino-acid labels and share some geometric
feature, then score the alignment produced from superimposing
these residue triplets. The highest scoring alignment produced
from a series of triplet superimpositions can then be used to
produce a set of residues conserved across a pair of samples (we
term this a pair-wise consensus set). This approach has been
employed in a hash table. For all samples every triplet of residues is
stored based on the amino-acid labels of its members and the inter-
residue distances are indexed. Each entry of the table can be
thought of as a triangle with vertices labeled according to amino
acid. Between pairs of samples highly congruent triangles with
matching vertices are used as candidate triplets likely to produce
high scoring superimpositions. Such criteria reduce the time spent
on triplets least likely to be part of the final pair-wise consensus set.
We have used congruency criteria of 1–10% as indicated below,
i.e. corresponding vertices must have magnitudes within 1–10% of
each other.
The method of superimposition is taken from Procrustes.
Candidate triplets from each sample i are stored in an 363
coordinate matrix Xi. These matrices are first Helmertized
(centered), removing translational differences:
_ X Xi~HT HXi, ð1Þ
where _ X Xi is the centered matrix and H the (m21)6m Helmert sub-
matrix whose j
th row is equal to (hj,…, hj, 2jhj,0,…,0) for
hj=2[j(j+1)]
21/2. Other approaches for removing translation are
available. The optimal rotation of _ X Xi onto _ X Xj is found byminimizing
_ X Xj{ _ X XiC
        2
, ð2Þ
where C isa 363 rotation matrix.It can be shownthat ifVDU
T isthe
singularvaluedecompositionof _ X XT
j _ X Xi,theoptimalrotationC=UV
T
(provisions must be made to ensure C does not also encompass
a reflection).
The translation resulting from centering triplets is then applied
to each structure and the appropriate sample is rotated by C. This
superimposes the equivalent triplet residues and pulls the rest of
each structure along. The result is that the initial pair-wise
consensus set a triplet comprises may be extended from the
structure-wide superimposition. Residues from the superimposed
structures are considered to be equivalent (i.e. in the pair-wise
consensus set) if they are identical or similar amino acids within
two angstroms of one another. Similar means sharing a category,
with those allowed including acidic (D, E, Z), aliphatic (A, G, I, L,
V), aromatic (F, H, W, Y), basic (H, K, R), charged (D, E, H, K,
R, Z), hydrophobic (A, C, F, G, I, L, M, P, V, W, Y), polar (C, D,
E, H, K, N, Q, R, S, T, Y, Z), small (A, C, D, G, N, P, S, T, V)
and very small (A, G, S), where Z refers to a phosphorylated
serine, threonine or tyrosine.
This procedure is performed on all triplets that match the
congruency criteria and all alignments are scored based on the
frequency with which the amino acids of any equivalent residues
occur. The frequency of occurrence for each amino acid was
obtained from the protein knowledge-base release statistics of
Swiss-Prot (Release 49.5, 18/04/06). Tryptophan is the lowest
occurring amino acid and superimposed tryptophans are therefore
given a score of one. All other scores are relative to that of
tryptophan: score(amino acid x)=occurrence(W/x). The occur-
rence of each category is equal to the sum of the occurrences of its
members. For m equivalent residues, the alignment score is
X m
i~1
occurrence W=xi ðÞ , ð3Þ
where xi is the amino acid or amino-acid category of the i
th
equivalent residue.
The top 100 scoring triplets are subjected to a second phase of
testing to find maximum similarity between two structures. For
these triplets the initial pair-wise consensus set is used for a second
superimposition. In this case the Xi coordinate matrices take on
dimensions m63, for m equivalent residues in the pair-wise
consensus set. The superimposition and extension steps are
repeated until a final non-extendable set is obtained.
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First, as has been mentioned, congruency between triangles is used
to reduce the number of triplets tested. Second, the vertices of
these triplets are only indexed by amino acid and not by category
as well. If vertices could be indexed by amino-acid category, such
as hydrophobic, the number of candidate triplets to search scales
tremendously, as does demands upon memory if a hash table is
employed. Third, we restrict triplets to a core of residues. For
a structure of 300 residues there are nearly 27 million candidate
triplets. Storing all in a hash table is too demanding, and is not
necessary either. The best candidate triplets will be clustered in
a core, which may be comprised of residues around an active site,
ligand binding domain or phosphorylation site. Only searching
this core will provide good candidate triplets and minimize time.
By default a geometric core of fifty residues is used.
From the input structures a consensus set Sn is sought for of
residues fully conserved across all n samples (a full consensus set).
This can be done quickly through a series of pair-wise
comparisons. First a consensus set S2 of conserved residues is
sought for between samples 1 and 2 using the superimposition
procedure outlined above. A second set S3 of conserved residues
found in S2 and sample 3 is then sought for using the same
procedure of selecting triplets from the consensus set and the
sample. This process is repeated until a final full consensus set Sn is
produced.Fromexperience theprocedureforderivingSnisgenerally
sample order independent, except in some cases where an extreme
outlier is present. This is a structure with few of the conserved
residues found across the other n21 samples. In this case the outlier
may align well with a set of residues conserved across the first x
samplesbutnotacrossthefinaln2x21.Byaligningwellwithasubset
of Sx not in Sn, the outlier skews the derivation process away from the
true set Sn. This can be accounted for by leaving such outliers until
the end, by which time the consensus set has been reduced to a true
group of highly conserved residues.
The multiple alignment procedure is a modification of the pair-
wise superimposition method outlined above. The full consensus
set Sn found through the pair-wise superimpositions is comprised of
a set of m landmarks that can be used to simultaneously align the
group of n structures. First, the conserved residues from each
sample i are stored in an m63 matrix Xi and Helmertized. The
optimal rotation matrix for each structure Ci is calculated by an








_ X XiCi{ _ X XjCj
       
2
: ð4Þ
The rotation Ci is calculated from the singular value decompo-
sition of _ X Xi with the mean of the rest, X
T






_ X Xj: ð5Þ
However, with each successive _ X Xi rotated, the previous Xj for j,i
will change and the previously calculated rotation of _ X Xj will be
incorrect. To account for this, after every sample has been rotated
G is calculated and the process of rotation is repeated until the
change in G falls below some arbitrary small threshold (i.e.
convergence occurs). For p steps until convergence, the optimal
rotation of each structure is equal to the product of the successive
Ci rotations.
This procedure superimposes the conserved residues found in
the set Sn. The next goal is to extend this set. Multiple alignment is
more accurate than a series of pair-wise alignments and this allows
for Sn to be extended to include additional fully conserved residues.
At the same time residues with less than full conservation can be
incorporated. We have defined conserved residues as identical or
similar amino acids from different structures within two angstroms
of some point, termed a consensus point. Consensus points are
considered redundant if they contain more than 50% of the same
residues. The point closer to the relevant landmarks is retained.
Partially conserved residues must only be present in a threshold of
samples and the less than full conservation of an amino acid takes
precedence over the conservation of a category. Leeway in the
conservation of residues allows for evolutionary freedom, but is
also required for practical reasons such as x-ray resolution, model
construction, side-chain movement and non-significant sample-
dependent positionings. As the superimposition procedure requires
all landmarks in all samples, any samples with missing landmarks
are temporally given the consensus point as a place filler. If new
residues can be added following an alignment then the expanded
set Sn is used to re-align the structures. The extension and
alignment process is repeated until a final consensus set is
converged upon or until the completion of a predetermined
number of iterations.
Aligning active-conformation kinases
Active-conformation kinases were aligned using the above pro-
cedure with a congruency criteria of 1% and a distance constraint
for conservation of two angstroms. The partially active-conforma-
tion structure of the transient receptor potential channel kinase
was aligned directly onto the consensus using congruency criteria
of 10% and a distance constraint of 2.25 angstroms.
Availability and Performance
The program is written in C and Fortran. Full source code is freely
available under the GNU General Public License by contacting
the authors. PDB formatted files are required for input. For
multiple alignments output consists of PDB files modified
according to the alignment, a consensus structure in PDB format,
a csv file indicating the conserved and aligned residues, and a script
for viewing the alignment and consensus in the open-source
program PyMOL (http://www.pymol.org). For a pair-wise
alignment against a consensus structure, output is as above except
no consensus structure is produced. The alignment and consensus
structure of the fifteen kinases presented in the Results section
were generated in ,twenty seconds using a single processing core
of an AMD Athlon 64 X2 4200 processor with 1GB of RAM. A
single pair-wise alignment takes ,2–8 seconds depending upon
the degree of similarity between input samples. Comparisons
between a sample and a consensus structure are very rapid
(,1 second due to the reduced set of residues in a consensus set).
Structure prediction
Constraints from fourteen active-conformation kinases were
generated for both the side-chain and the a-carbon. Constraints
were derived from the final structural alignment. Side-chain
constraints were applied to the atom closest to the median of all
side-chain atoms. Structure models were created following the
Rosetta homology modeling protocol described in Das et al. [30].
During full-atom refinement of a model, a penalty score is applied
when the atom-atom distances in the model exceed the upper or
lower limit of the corresponding distance constraints. If a distance
exceeds the upper or lower constraint limit by d Angstrom, then
the penalty score Ec is d*d when d,0.5 and d20.25 when d$0.5.
For PDK1, the lowest scoring model (in full atom energy) as
Modeling Protein Kinases
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lowest 5% of models were used for screening against the consensus
structure as described in the Results section. Models were ranked
based on their score from Equation.
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0000982.s001 (0.23 MB
DOC)
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